| Akoya Biosciences is a life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research. Spatial biology is an evolving technology that enables academic and biopharma scientists to detect and map the distribution of cell types and biomarkers across whole tissue samples at single-cell resolution, enabling advancements in their understanding of disease progression and patient response to therapy. Through its PhenoCycler and PhenoImager platforms, reagents, software and services, Co. provides solutions to perform tissue analysis and spatial phenotyping across the continuum from discovery through translational and clinical research. We show 11 historical shares outstanding datapoints in our AKYA shares outstanding history coverage, used to compute AKYA market cap on those dates.|
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing AKYA market cap history over the course of time is important for investors
interested in comparing AKYA's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of AKYA versus a peer is one thing; comparing
AKYA market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like AKYA can fluctuate over the course of history.
With this page we aim to empower investors researching AKYA by allowing them to research the AKYA market cap history.